CHARLESTON, S.C. (WCBD) – The Medical University of South Carolina (MUSC) and Shriners Hospitals for Children announced Wednesday a new affiliation to support the state’s only comprehensive pediatric ...

NORTH LAS VEGAS (KTNV) — The holidays are a special time to celebrate loved ones and those who care for them. On Saturday, pediatric burn survivors and their families celebrated their resilience and ...

NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes. The Food and Drug Administration (FDA) has expanded the approval of ...

CHARLESTON, S.C. (WCSC) - Leaders with MUSC and Shriners Hospital for Children announced a partnership to continue pediatric burn care for children in the Lowcountry on Wednesday. MUSC and Shriner’s ...

SACRAMENTO, Calif., Feb. 5, 2024 /PRNewswire/ -- Shriners Children's, an internationally recognized expert in pediatric burn care, sees more than 3,000 children each year as a result of burn injuries ...

Findings in Burns Journal confirm NexoBrid’s superiority over standard of care in pediatric patients with deep thermal burnsNexoBrid is approved for pediatric use in the U.S., E.U. and Japan YAVNE, ...

Tampa, Fla.-based Shriners Hospitals for Children reneged on plans to discontinue pediatric burn services at its Boston location, The Boston Globe reports. Shriners revealed plans in March to ...

Please provide your email address to receive an email when new articles are posted on . NexoBrid was approved for the treatment of deep partial-thickness and full-thickness thermal burns in adults in ...

LAS VEGAS, Nev. (FOX5) - On Saturday, University Medical Center’s Lions Burn Care Center held its 21st annual Little Roar Holiday Party – where pediatric burn survivors and their families got to ...

Spectral AI, a Dallas-based company specializing in AI-driven medical diagnostics, has completed pediatric enrollment for its U.S. Burn Pivotal Study, one of the largest domestic studies focused on ...

YAVNE, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced the publication of its ...